Concepedia

Mark Legacy

ML

Statistics

Publications

1

Citations

47

H-Index

1

Active since

2021

Affiliations

Fraser Health(Current)

Mark Legacy is an author at Fraser Health specializing in melatonin supplementation, non-small cell lung cancer adjuvant therapy, and melatonin treatment.

ORCID

Publications per year

2021–2021

1

Publications

1

Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial

Dugald Seely, Mark Legacy, Rebecca C. Auer et al. · EClinicalMedicine · 2021 · 47 citations · Full text

Medicine, Oncology, Pharmacology +14

1–1 of 1